Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease

BMC Pulmonary Medicine

Table 1 Demographic and clinical characteristics of the CF patients

∆F 508 homozygous mutation^a	31/79 (40%)
Smoker^a	10/102 (10%)
Oxygen supplementation^a	11/95 (11%)
ABPA^a	33/95 (35%)
Exocrine pancreatic insufficiency^a	78/102 (76%)
Diabetes^a	21/102 (21%)
Nasal polyposis^a	25/94 (27%)
BMI, kg/m^2b	20 (20 ± 3)
Lean body mass, kg^b	45 (48 ± 9)
Pseudomonas aeruginosa ^a	63/99 (63%)
Staphylococcus aureus MS^a	36/99 (36%)
Mycobacterium abscess^a	4/99 (4%)
Blood leukocytes, 10¹²/mm^3b	9 (9.7 ± 3.8)
Blood polymorphonuclear neutrophils, 10¹²/mm^3b	6 (6.4 ± 3.3)
CRP, mg/L^b	5.5 (15 ± 30)
Serum albumin, g/L^b	42 (42 ± 4)

ABPA = allergic bronchopulmonary aspergillosis; BMI = body mass index; CRP = C-reactive protein.
Qualitative variables are given as frequency and percentage.
^aResults are expressed as number (percentage) of patients.
^bResults are expressed as median values (mean ± SD).

ISSN: 1471-2466